Abstract
Activation of the immune system in heart failure (HF) has been recognized for over 20 years. Initially, experimental studies demonstrated a maladaptive role of the immune system. However, several phase III trials failed to show beneficial effects in HF with therapies directed against an immune activation. Preclinical studies today describe positive and negative effects of immune activation in HF. These different effects depend on timing and aetiology of HF. Therefore, herein we give a detailed review on immune mechanisms and their importance for the development of HF with a special focus on commonalities and differences between different forms of cardiomyopathies. The role of the immune system in ischaemic, hypertensive, diabetic, toxic, viral, genetic, peripartum, and autoimmune cardiomyopathy is discussed in depth. Overall, initial damage to the heart leads to disease specific activation of the immune system whereas in the chronic phase of HF overlapping mechanisms occur in different aetiologies.
Original language | English |
---|---|
Pages (from-to) | 445-459 |
Number of pages | 15 |
Journal | European Journal of Heart Failure |
Volume | 20 |
Issue number | 3 |
Early online date | 15 Jan 2018 |
DOIs | |
Publication status | Published - Mar 2018 |
Bibliographical note
Funded byRegione Campania CISI-Lab
European Union Commission's Seventh Framework . Grant Number: 305507, 602904
FP7-Health-2013-Innovations-1. Grant Number: 602156
FWO Flanders, Belgium. Grant Number: FWO G080014 N
European Union Horizon2020. Grant Number: UE LSHM-CT-05-018833, FNRS PDR T.0144.13
Bundesministerium für Bildung und Forschung. Grant Number: BMBF01 EO1004
Deutsche Forschungsgemeinschaft. Grant Number: SFB688 TP A10
Keywords
- Journal Article
- Review